What is GHK-Cu?
GHK-Cu (Glycine-Histidine-Lysine:Copper) is a naturally occurring tripeptide that forms a complex with copper(II) ions. It was first isolated from human plasma in 1973 by Dr. Loren Pickart, who discovered it had a remarkable ability to stimulate liver tissue regeneration.
Since then, GHK-Cu has been found in saliva, urine, and cerebrospinal fluid. Its levels decline significantly with age — from approximately 200 ng/mL in young adults to around 80 ng/mL by age 60 — prompting interest in its role in aging and tissue maintenance.
How GHK-Cu Works
GHK-Cu operates through multiple pathways:
- Gene regulation: Research indicates GHK-Cu can up- or downregulate hundreds of genes involved in tissue remodeling, inflammation, and nervous system function
- Collagen synthesis: Stimulates fibroblasts to produce collagen and glycosaminoglycans
- Antioxidant activity: The copper complex provides free radical scavenging activity
- Angiogenesis: Promotes new blood vessel formation to support healing tissue
- Stem cell activation: May stimulate stem cells in hair follicles and skin
Research Summary
Skin Applications
GHK-Cu is one of the most researched peptides in dermatology. Multiple clinical studies support its use in:
- Reducing fine lines and wrinkles
- Improving skin elasticity and firmness
- Accelerating wound closure and reducing scar formation
- Evening skin tone and improving overall texture
Hair Growth
Some clinical evidence supports GHK-Cu’s ability to stimulate hair follicle activity and reduce hair loss, particularly in androgenetic alopecia.
Systemic Effects
Emerging research suggests systemic GHK-Cu may have broad regulatory effects on gene expression, with potential applications in wound healing, cancer protection, and neurological health — though most of this research remains preclinical.
Safety Considerations
- Topical use: Extensive safety record in cosmetic products; generally well-tolerated
- Injectable use: Limited human safety data; not FDA-approved for systemic administration
- Copper excess can be toxic; proper dosing is important for any systemic application
Medical Disclaimer: This content is for educational purposes only. GHK-Cu as a systemic agent is not approved by the FDA. Always consult a healthcare provider before using peptides therapeutically.
Regulatory Status
As a topical cosmetic ingredient, GHK-Cu is legal in the United States and widely available in skincare products. For systemic/injectable use, it occupies a regulatory gray area and is not FDA-approved as a drug.
Related Reading
- GHK-Cu: The Copper Peptide Research Guide — Comprehensive review of GHK-Cu’s skin, wound healing, and gene regulation data
- Anti-Aging Peptides: What the Research Actually Shows — GHK-Cu in context with other anti-aging peptide candidates
- Peptide Therapy and Women’s Health — Skin collagen loss with age and topical peptide evidence
- Peptide Therapy for Aging and Sarcopenia — Connective tissue peptides in a broader longevity strategy
Safety Profile Summary
GHK-Cu has a well-established topical safety profile and is used in numerous FDA-compliant cosmetic formulations. Injectable or systemic use has less established human safety data.
References & Further Reading
- 1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. [PubMed ↗]
- 2. Pickart L, et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. [PubMed ↗]
- 3. Gorouhi F, Maibach HI. Role of Topical Peptides in Preventing or Treating Aged Skin. Int J Cosmet Sci. 2009;31(5):327-45. [PubMed ↗]
- 4. Pickart L. The Human Tri-Peptide GHK and Tissue Remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88. [PubMed ↗]